H7c82f9e798154899b6bc46decf88f25eO
H9d9045b0ce4646d188c00edb75c42b9ek

COVID-19 Antigen Rapid Test Cassettes AMRDT106

Takaitaccen Bayani:

Sunan samfur:COVID-19 Antigen Rapid Test Cassettes AMRDT106 na siyarwa |Medsinglong
Sabon Farashi:

Samfurin No.:Saukewa: AMRDT106
Nauyi:Net nauyi: Kg
Mafi ƙarancin oda:1 Saita/Saiti
Ikon bayarwa:Saiti 300 a kowace shekara
Sharuɗɗan Biyan kuɗi:T/T,L/C,D/A,D/P,Western Union,MoneyGram,PayPal


Cikakken Bayani

Tags samfurin

Cikakken Bayani

Samfura:
Abubuwan da aka gano sun haɗa da swab na nasopharyngeal da swab na oropharyngeal.
Samfurin shirye-shiryen na iya ɗauka bisa ga matakan aiki.
1.Specimen hakar reagent
2.Bari swab a cikin bututun reagent na minti daya.
3.Cinci bututun hakar da yatsu.
4.Saka bututun ƙarfe.

Marufi & Bayarwa

Cikakken bayanin marufi: daidaitaccen fakitin fitarwa
Bayanin isarwa: a cikin kwanakin aiki 7-10 bayan an karɓi biyan kuɗi

Ƙayyadaddun bayanai

COVID-19 Antigen Rapid Test Cassette AMRDT106:

Ganewar Protein Nucleocapsid SARS-CoV-2:
Nucleocapsid (N) furotin shine mafi yawan furotin tare da kiyaye shi sosai a cikin SARS-CoV-2.
Ana amfani da furotin N azaman ainihin albarkatun ƙasa na saurin gano maganin rigakafi a cikin kasuwa.

COVID-19 Antigen Rapid Test Cassette Wanda Clongene ya Haɓaka:
Clongene ya haɓaka kaset ɗin gwajin gaggawa na Antigen na COVID-19. The colloidal gold immunoassay
(CGIA) don gano furotin nucleocapsid na SARS-CoV-2 ya dogara ne akan ka'idar fasahar rigakafin mutum-sandi.

AMFANI DA NUFIN:

The COVID-19 Antigen Rapid Cassette shine gwajin gwajin jini na gefe wanda aka yi niyya don gano ƙimar SARS-CoV-2 nucleocapsid antigens a cikin swab na nasopharyngeal da swab na oropharyngeal daga mutanen da ake zargin suna da Covid-19 ta hanyar mai ba da lafiyar su. Sakamako shine don ganewa. na SARS-CoV-2 nucleocapsid antigen.Antigen gabaɗaya ana iya ganowa a cikin swab na nasopharyngeal da swab na oropharyngeal a lokacin matsanancin lokaci na kamuwa da cuta.Sakamako mai kyau yana nuna kasancewar antigens na hoto ko bidiyo mai zagaya yanar gizo da sauri, amma alaƙar asibiti tare da tarihin haƙuri da sauran bayanan bincike ya zama dole don tantance kamuwa da cuta. Matsayi.Sakamako mai kyau baya kawar da kamuwa da cutar kwayan cuta ko kamuwa da cuta tare da wasu ƙwayoyin cuta.Wakilin da aka gano bazai zama tabbataccen dalilin cutar ba.Sakamako mara kyau baya kawar da kamuwa da cutar SARS-CoV-2 kuma bai kamata a yi amfani da shi azaman tafin kafa ba. tushen jiyya ko yanke shawara na gudanarwa na haƙuri, gami da yanke shawarar sarrafa kamuwa da cuta.Ya kamata a yi la'akari da sakamako mara kyau a cikinmahallin bayyanar da majiyyaci kwanan nan, tarihi da kasancewar alamun asibiti da alamomin da suka yi daidai da COVID-19, kuma an tabbatar da su tare da gwajin ƙwayoyin cuta, idan ya cancanta don sarrafa haƙuri.CoVID-19 Antigen Rapid Cassette an yi nufin amfani da shi ta hanyar horarwa ta asibiti. ma'aikatan dakin gwaje-gwaje sun ba da umarni na musamman da kuma horar da hanyoyin bincike na in vitro.

Samfura:
Abubuwan da aka gano sun haɗa da swab na nasopharyngeal da swab na oropharyngeal.
Samfurin shirye-shiryen na iya ɗauka bisa ga matakan aiki.
1.Specimen hakar reagent
2.Bari swab a cikin bututun reagent na minti daya.
3.Cinci bututun hakar da yatsu.
4.Saka bututun ƙarfe.


KASHI:
Kaset ɗin gwajin ya ƙunshi tsiri mai laushi wanda aka lulluɓe da anti-SARS-CoV-2 nuclenocapsid protein monoclonal antibody akan layin gwajin T, da kushin rini wanda ya ƙunshi zinare colloidal haɗe da SARS-CoV-2 nuclenocapsid protein monoclonal antibody.


  • Na baya:
  • Na gaba:

  • Bar Saƙonku:

    Ku rubuta sakonku anan ku aiko mana.

    Bar Saƙonku:

    Ku rubuta sakonku anan ku aiko mana.